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Abstract 
The importance of the working document is that it allows the analysis of the information and the status of 
cases associated with (SARS-CoV-2) COVID-19 as open data at the municipal, state and national level, with a 
daily record of patients, according to a age, sex, comorbidities, for the condition of (SARS-CoV-2) COVID-19 
according to the following characteristics: a) Positive, b) Negative, c) Suspicious. Likewise, it presents 
information related to the identification of an outpatient and / or hospitalized patient, attending to their 
medical development, identifying: a) Recovered, b) Deaths and c) Active, in Phase 3 and Phase 4, in the five 
main population areas speaker of indigenous language in the State of Veracruz - Mexico. The data analysis is 
carried out through the application of a data mining algorithm, which provides the information, fast and 
timely, required for the estimation of Medical Care Scenarios of (SARS-CoV-2) COVID-19, as well as for know 
the impact on the indigenous language speaking population in Veracruz. For this purpose, the following study 
zones are presented: a) Totonacapan Zone, b) Huasteco from the Tantoyuca Zone, c) Otomi from the 
Inxhuatlan de Madero Zone, d) Nahuatl from the Zongolica Zone, e) Nahuatl from the Chicontepec Zone, f) 
Nahualt from the Pajapan Zone and g) Popoluca from the Soteapan Zone. This data article presents the 
information as of August 1, 2020 corresponding to the the Nahuatl from the Pajapan Zone. 
Keywords 
(SARS-CoV-2) COVID-19, Algorithm (SARS-CoV-2) COVID-19, Mexico, identification of patients, Popoluca 
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Specifications Table 
Subject Infectious Diseases 
Specific subject area Information from the Viral Respiratory Diseases Epidemiological 
Surveillance System for (SARS-CoV-2) COVID-19 in Mexico corresponding 
to the Nahuatl from the Pajapan  Zone. 
Type of data Table 
Figure 
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How data were acquired Government of Mexico. Health Secretary. Databases Covid-19 México 
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos- 
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 
Instruments: 
Software Orange Data Mining version 3.26.0 https://orange.biolab.si 
Make and model and of the instruments used: 
Algorithm for the identification of patients according to following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets 
Data format The information is presented in raw in CVS format, the Ministry of Health 
of Mexico since April 14, 2020 published the cases associated with (SARS- 
CoV-2) COVID-19 as open data. The data processing corresponds to the 
records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The 
treatment of the information is carried out through the application 
software for data mining Orange version 3.26.0, in which the algorithm for 
the analysis of information is filtered to present the current scenario of the 
Nahuatl from the Pajapan  Zone in Mexico of the SARS-CoV-2 (COVID 19). 
Parameters for data 
collection 
The information is presented at the municipal, state and national levels, 
with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets. 
Study area The municipalities that comprise the Nahuatl from the Pajapan  Zone are:  
Coatzacoalcos, Cosoleacaque, Mecayapan, Minatitlán, Oteapan, Pajapan, 
Soteapan, Zaragoza, Tatahuicapan de Juarez. 
Description of data 
collection 
This information is filtered to present the current scenario in the Nahuatl 
from the Pajapan  Zone in Mexico of the SARS-CoV-2 (COVID 19) in a fast 
and timely manner, to support public decision-making in health matters. 
Data source location Institution: Universidad Veracruzana / Instituto de Investigaciones y 
Estudios Superiores Económicos y Sociales 
Country: México 
Data accessibility Raw data can be retrieved from the Github repository 
https://github.com/CMedelR/dataCovid19/edit/master/README.md 
 
 
 
Value of the Data 
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• The Algorithm for the identification of patients (SARS-CoV-2) COVID 19 in Mexico allows to analyze at 
the municipal, state and national level, the registry of patients, according to age, sex, comorbidities, 
for condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) Positive, b) 
Negative, c) Suspicious, as well as presenting information on the identification of an outpatient and / 
or hospitalized patient, attending to their medical development, identifying: a) Recovered, b ) Deaths 
and c) Assets, in Phase 3 and Phase 4, in a fast and timely manner, to support public decision-making 
in health matters. 
• Taking into account their strategic roles in public health and researchers can use the data from this 
study to identify the action scenario for decision-making in the combat of (SARS-CoV-2) COVID 19 in 
Phase 3 and Phase 4 corresponding to the Popoluca from the Soteapan Area 
• The importance of data analysis is that it allows identifying cases (SARS-CoV-2). COVID-19 in Mexico 
is concentrated daily and knowing the impact on the population and allows preparing action scenarios 
to make public health policy decisions to combat SARS-CoV-2) COVID-19 in the main five areas that 
concentrate the speaking population of Nahuatl, Totonaco, Huasteco, Popoluca, Otomi in Veracruz 
Mexico. 
 
Data Description 
 
The source of information on the number of registered cases of (SARS-CoV-2) COVID-19 at 1 August 2020 for 
Mexico comes from the website https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid- 
19-en-mexico by the Ministry of Health, with the participation of the National Council for Science and 
Technology (CONACYT), the Center for Research in Geospatial Information Sciences (CENTROGEO), the 
National Laboratory for Geo-Intelligence (GEOINT), the Data Laboratory of the National Laboratory for 
Geointelligence (DataLab), where the registry of COVID-19 cases (SARS-CoV-2) COVID-19 is concentrated, and 
is the official means of communication and information on the epidemic in the Popoluca from the Soteapan 
Area in Mexico. 
 
The information of the cases (SARS-CoV-2) COVID-19 in Mexico is concentrated on a daily basis since April 19, 
2020, communication and official information on the epidemic in Mexico, the data are presented at the 
municipal, state and national levels, with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) Positive, b) Negatives, 
c) Suspects. Likewise, it presents information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: a) Recovered, b) Deaths and c) 
Assets. The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 
2020. The treatment of the information is carried out through the application software for data mining and 
visual programming Orange Data Mining version 3.26.0. Orange Data Mining is a machine learning and data 
mining suite for data analysis through Python scripting and visual programming. [1] 
 
According to (WHO, 2020) the (SARS-CoV-2) COVID-19 disease pattern presents 4 scenarios identified from 
the confirmation of Laboratory Diagnosis: a) Not Infected or b) Infected, in this finally, the following categories 
are observed, taking into account age and specific comorbidities in each case: a) Mild Infection, b) Moderate 
Infection, c) Severe Infection and d) Critical Infection. 
 
Depending on the category observed in Patients who have a Confirmation of Infected, as in the case of a) or 
b) it can assume the character of Outpatient, so the strategy is isolation or "quarantine" at home, where the 
result It is hoped that he will recover. Regarding the Patients who have a Confirmation of Infected, in 
categories c) and d) they assume the character of Hospitalized Patient, with a probability of requiring care in 
Intensive Care Units and requiring Intubation, and where it is hoped to save as many patients as possible. 
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The importance of the research is that it allows identifying the action scenario for making public health policy 
decisions to combat CO(SARS-CoV-2) COVID-19, since they consider the following states of process in medical 
treatment, in order to carry out the Estimate of Scenarios for Medical Care of the (SARS-CoV-2) COVID-19 
under the following premises of hospital care: 
1. A patient with a positive (SARS-CoV-2) COVID-19 laboratory diagnosis can be considered: a) Outpatient, 
or b) Hospitalized. 
2. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized, the following should be considered: a) 
Enter the Intensive Care Unit or b) Do not enter the Intensive Care Unit. 
3. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized and Entered into the Intensive Care Unit, 
the following should be considered: a) The patient requires intubation or b) The patient does NOT require 
intubation. 
 
Methods 
 
The information is presented in raw in CVS format, the Ministry of Health of Mexico. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The treatment of the 
information is carried out through the application software for data mining Orange version 3.26.0, in which 
the algorithm for the analysis of information are developed and it is filtered to present the current scenario 
in Mexico of the SARS-CoV-2 (COVID 19). In this way, the algorithm that is presented allows us to project the 
requirements for the use of installed infrastructure in the face of the growing requirement for patient care 
Positive (SARS-CoV-2) COVID-19, allowing the identification of scenarios at the national, state and municipal 
levels. The construction of the algorithm is based on the following definitions. 
 
Definition 1: Total Patients to consider in Model (SARS-CoV-2) COVID-19.- It is the number of total patients 
according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to (SARS-CoV-2) COVID-19 confirmatory laboratory result 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- SARS-CoV-2 i j) + (Px SARS-CoV-2 i j), where: i = State, j = 
Municipality 
Of which: 
P+ SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- SARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px SARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 2: Identification of a suspected (SARS-CoV-2) COVID-19 case.- This is the patient who undergoes 
an initial qualification according to the initial diagnostic characteristics indicated in the case definitions for 
surveillance by the World Health Organization for primary care of (SARS-CoV-2) COVID-19 cases. 
Be: 
CsCOVID 19 (SARS-CoV-2) = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID-19 
Where: 
Cs (SARS-CoV-2) COVID-19 = Cs (SARS-CoV-2) COVID-19 Type 1 + Cs (SARS-CoV-2) COVID-19 Type 2 + Cs (SARS- 
CoV-2) COVID-19 Type 3 
Of which: 
According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 3) 
to identify suspected cases of (SARS-CoV-2) COVID-19, defined below: 
1. Cs (SARS-CoV-2) COVID-19 Type 1.- Is a patient with acute respiratory disease (fever and at least one 
sign / symptom of respiratory disease, with no other aetiology that fully explains the clinical 
presentation and a history of travel or residence in a country / area or territory that reports local 
transmission of COVID-19 disease during the 14 days prior to the onset of symptoms. 
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2. Cs (SARS-CoV-2) COVID-19 Type 2.- He is a patient with an acute respiratory disease, who has been in 
contact with a confirmed or probable COVID-19 case in the last 14 days before the onset of symptoms. 
3. Cs (SARS-CoV-2) COVID-19 Type 3.- Is a patient with severe acute respiratory infection (fever and at 
least one sign / symptom of respiratory illness (eg cough, shortness of breath) and requiring 
hospitalization and without another etiology that fully explains the clinical presentation. 
 
Definition 3: Total Patients to consider in the (SARS-CoV-2) COVID-19 Model .- It is the number of total 
patients according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to confirmatory laboratory result or not of (SARS-CoV-2) COVID- 
19 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- ARS-CoV-2 i j) + (Px ARS-CoV-2 i j) , where: i = State, j = 
Municipality 
Of which: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- ARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px ARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 4: Positive Patients for (SARS-CoV-2) COVID-19 i j.- It is the number of patients with laboratory 
results with positive confirmation for (SARS-CoV-2) COVID-19 i j . 
It has: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
 
Definition 5.- Medical Treatment Strategy for a patient with positive laboratory confirmation for (SARS-CoV- 
2) COVID-19 i j .- It is the Action Plan in Medical Treatment for a patient with positive laboratory confirmation 
for SARS-CoV-2 in attention to your degree of infection and comorbidities present that is channeled to 
determine the Physician. 
 
According to the Strategy of Medical Care required for Patients with a Positive SARS-CoV-2 Result, according 
to their degree of identified infection, they have the following. 
Be: 
ET P + SARS-CoV-2 i j = Medical Treatment Strategy P + SARS-CoV-2 i j 
 
The medical treatment for a patient with a positive laboratory result for (SARS-CoV-2) COVID-19, based on 
the Medical Treatment Strategy (ETM P + SARS-CoV-2 ij), based on his degree of infection and present 
comorbidities, poses two action scenarios : i) Outpatient (SARS-CoV-2) COVID-19 patient or ii) Hospitalized 
(SARS-CoV-2) COVID-19 patient. 
Be: 
i) Outpatient COVID19 patient. 
P + SARS-CoV-2 i j Outpatient = Positive (SARS-CoV-2) COVID-19 with Outpatient mode in the State, 
Municipality 
ii) COVID19 Patient Hospitalized. 
P + SARS-CoV-2 i j Hospitalized = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the State, 
Municipality 
where: 
Depending on the degree of infection (I1, I2 or I3), the Hospitalized (SARS-CoV-2) COVID-19 Patient may 
require: i) Access to the Intensive Care Area without Intubation or ii) Access to the Intensive Care Area with 
Intubation. 
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Definition 6.- Patients with a Positive (SARS-CoV-2) COVID-19 Result Hospitalized with Access to the 
Intensive Care area.- It is the number of Patients with a Positive SARS-CoV-2 Result Hospitalized with Access 
to the Intensive Care area, according to its degree of infection. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care = Positive (SARS-CoV-2) COVID-19 with modality 
Hospitalized in the State, Municipality 
Definition 7.- Patients with a positive (SARS-CoV-2) COVID-19 result Hospitalized with access to the Intensive 
Care Area with Intubation.- It is the number of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
Hospitalized with Access to the Intensive Care area with Intubation. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care with Intubation = Positive (SARS-CoV-2) COVID-19 with Hospitalized 
modality and intubation in the State, Municipality. 
 
Definition 8.- P + SARS-CoV-2 i j Deaths.- Deaths of Patients with a positive result for SARS-CoV-2. Deaths are 
all those positive to (SARS-CoV-2) COVID-19 where one is indicated in the data record (DATE_DEF other than 
the value "99-99-9999"). 
 
Definition 9.- (SARS-CoV-2) COVID-19 case fatality rate.- It is the proportion of people who die from (SARS- 
CoV-2) COVID-19 among the Patients with a positive (SARS-CoV-2) COVID-19 result in a given period and area. 
Be: 
TL SARS-CoV-2 i j = (SARS-CoV-2) COVID-19 case fatality rate 
Where: 
(SARS-CoV-2) COVID-19 case fatality rate = [(Deaths of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
in the State or Municipality) / (Total of Patients with a Positive (SARS-CoV-2) COVID-19 result in the State or 
Municipality)] x 100 
Of which: 
DP+ SARS-CoV-2 i j = Deaths of Patients with a positive (SARS-CoV-2) COVID-19 result in the State / 
Municipality 
And: 
P+ SARS-CoV-2 i j = Total Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality 
So: 
TL SARS-CoV-2 i j = [D P + SARS-CoV-2 i j / P + SARS-CoV-2 i j] x 100 
 
The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. 
The treatment of the information is carried out through the application software for data mining Orange 
version 3.26.0, in which the algorithm for the information analysis are developed. (See Figure 1, below). 
According to information from the Ministry of Health, the following records are available at the national level: 
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Figure 1. Algorithm for the identification of patients 
(SARS-CoV-2) COVID 19 in the Nahuatl from the Pajapan Zone 
in Mexico Orange Data Mining version 3.26.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Self made. With information provided by the Ministry of Health as of 1 June 2020 and Orange 
Data Mining version 3.25.1 
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According to information from the Ministry of Health in Mexico, the following records are available at the 
national level: 
 
1. The total number of cases in Mexico as of august 1, 2020, is 999,697 cases of which, based on the 
confirmatory or non-laboratory result for (SARS-CoV-2) COVID-19, the following classification is 
obtained: a ) 434,193 patients with a positive result for (SARS-CoV-2) COVID-19, b) 477,733 patients 
with a non-positive result for (SARS-CoV-2) COVID-19 and c) 87,771 patients with a pending result to 
determine (SARS-CoV -2) COVID-19. (See table 1) 
2. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 434,193 of which: a) 316,860 
are care outpatients and b) 117,333 are hospitalized patients. (See table 2) 
3. The total number of patients (SARS-CoV-2) COVID-19 hospitalized (include positive and non positive 
results) is 192,214 of whom 78,088 are women and 114,126 are men. (See Table 3) 
4. The total number of hospitalized patients with a positive result for (SARS-CoV-2) COVID-19 is 117,219, 
of whom: a) 9,400 patients enter the intensive care unit; while b) 107,819 patients do not enter the 
intensive care unit. (See Table 4) 
5. Only 4,874 Hospitalized with a positive (SARS-CoV-2) COVID-19 patients admitted to the intensive 
care unit required intubation; while 4,526 patients did not require intubation. (See Table 5) 
6. Likewise, to date 42,158 deaths from positive (SARS-CoV-2) COVID-19 patients have been registered 
nationwide, of which 3,486 deaths corresponded to Positive (SARS-CoV-2) COVID-19 patients who 
were in intensive care and intubation and 38,672 corresponded to (SARS-CoV-2) COVID-19 positive 
patients who were not in intensive care. (See Table 6). 
7. The fatality rate of patients with a positive result for SARS-CoV-2) COVID-19 at nationwide as of august 
1, 2020, is estimated at 10.93%. The five states that registered the highest fatality rates as of August 
1, 2020 are the following: a) Morelos with a rate of 2039%, b) Baja California with 19.67%, c) Sinaloa 
with a rate of 17.46% , d) Colima with a rate of 17: 00% and e) State of Mexico with a rate of 15.37%. 
For its part, the State of Veracruz registered a rate of 13.20% while Mexico City registered a rate of 
9.75% (See Table 7). 
8. Figure 1 shows the main comorbidities identified in hospitalized patients with a positive result for 
(SARS-CoV-2) COVID-19, nationwide as of August 1, 2020. 
9. In the State of Veracruz, the total number of cases related to (SARS-CoV-2) COVID-19 as of August 1, 
2020 is 34,904 of which: a) 21,582 correspond to patients with positive confirmation for (SARS-CoV- 
2) COVID-19, b) 10,518 are patients with a negative result for (SARS-CoV-2) COVID-19 and c) 2,804 
are patients with results pending confirmation. (See Table 8). 
10. In the State of Veracruz, 4.97% of all patients with a positive result for (SARS-CoV-2) COVID-19 are 
concentrated at the national level as of August 1, 2020. (See Table 1 and Table 8). 
11. For its part, in the Popoluca from the Soteapan Area the total number of cases related to (SARS-CoV- 
2) COVID-19 as of August 1, 2020 is 3,967 of which: a) 2,505 ccorrespond to patients with positive 
confirmation for (SARS- CoV- 2) COVID-19, b) 1,274 are patients with a negative result for (SARS-CoV- 
2) COVID-19 and c) 188 are patients with results pending confirmation. (See Table 9). 
12. The percentage of patients with a positive result for (SARS-CoV-2) COVID-19 is 63.14% with respect 
to the total number of cases registered in the Popoluca from the Soteapan Area. (See Table 9). 
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According to information from the Ministry of Health, in the Nahuatl from the Pajapan  Zone the following 
records are available at the national level: 
 
1. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 2,505 of which: a) 1,050 
are women and b) 1,455 are men. (See Table 9). The total number of women with a positive (SARS-
CoV-2) COVID- 19, only 3 are women who speak the indigenous language and 1,047 are women 
who do not speak the indigenous language. On the other hand, the total number of men with a 
positive (SARS-CoV-2) COVID-19, 11 are men who speak the indigenous language and 1,444 are 
men who do not speak the indigenous language. (See Table 10). 
2. Of the 2,505 positive cases for (SARS-CoV-2) COVID 19, only 14 correspond to patients who speak 
an indigenous language and 2,491 are patients who are not speakers of an indigenous language. 
(See Table 11) 
3.  From the 2,505 patients with (SARS-CoV-2) positive COVID-19, according to their primary hospital 
care, there are: a) 1,268 are patients who did not require hospitalization and b) 1,237 are patients 
who required hospitalization. From the 1,237 patients with (SARS-CoV-2) COVID-19 positive who 
were hospitalized: a) 12 correspond to speakers of the indigenous language and b) 1,225 are 
patients who do not speak the indigenous language. The 1,268 patients with (SARS-CoV-2) COVID- 
19 positive who were not hospitalized, only 12 were patients speaking the indigenous language 
hospitalized and 1,266 were patients who did not speak the indigenous language hospitalized. 
(See Table 12). 
4. From the 14 patients who speak the indigenous language and required hospitalization, these 
come from: Coatzacoalcos 4 patient, Cosoleacaque 2, Minatitlan 5, Pajapan 1 and Soteapan 2. 
(See Table 13) 
5. From the 14 hospitalized (SARS-CoV-2) COVID-19 positive Indigenous language speaker patients : 
a) 0 patients enter the Intensive Care Unit; while b) 12 patients do not enter the Intensive Care 
Unit and 0 patient Hospitalized (SARS-CoV-2) COVID-19 Positive patients required intubation in 
Coatzacoalcos. (See Table 14). 
6. As of August 1, 2020 there have been 6 deaths of hospitalized patients (SARS-CoV-2) COVID-19 
whose results were positive and were indigenous language speakers in the Nahuatl from the 
Pajapan  Zone. (See Figure 2), at the end of the section, where the associated comorbidities of the 
indigenous language-speaking patients who died in the Nahuatl from the Pajapan  Zone, as August 
1 2020. 
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Table 1. Total number of cases in Mexico 1 August 2020, 
According to Sex and Result at (SARS-CoV-2) COVID-19 
 
  Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-19  203,284 230,909 434,193 
No positive (SARS-CoV-2) COVID-19      254,331 223,402       477,733 
Pending result 43,466 44,305         87,771 
Total 501,081 498,616       999,697 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
Table 2. Total number of cases in Mexico as of August 1, 2020, according to 
type of patient and result in (SARS-CoV-2) COVID-19 
 
  Patient type  
Result Ambulatory Hospitalized Total 
Positive (SARS-CoV-2) COVID-19  316,860  117,333 434,193 
No positive (SARS-CoV-2) COVID-19      418,514 59,219       477,733 
Pending result 72,109 15,662         87,771 
Total 807,483 192,214       999,697 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
Table 3. Total number of cases in Mexico as of August 1, 2020, according to sex 
and type of patient 
 
   Patient type                        
Sex Ambulatory Hospitalized  Total 
Women 422,993 78,088 501,081 
Men 384,490 114,126 498,616 
Total 807,483 192,214 999,697 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
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unit 
patient 
Table 4. Total number of cases in Mexico as of August 1, 2020, according 
type of patient and Intensive care unit 
Patient type 
Intensive care No Intensive care 
unit 
 
Total 
 
Hospitalized 9,400 107,819 117,219 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
Table 5. Total number of cases in Mexico as of August 1, 2020, according to 
hospitalized patient in intensive care unit and intubation condition 
 
 
Patient type 
Intubated
 
No Intubated 
patient 
Total 
Hospitalized 
intensive care 
unit 
 
4,874 4,526 9,400 
 
 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
Table 6. Number of deceased patients with positive COVID-19 (SARS- 
CoV-2), nationwide and according to hospital care condition 
as of August 1, 2020 
 
 
Source: Government of Mexico. Health Secretary. Information from the Epidemiological 
Surveillance System for Viral Respiratory Diseases 1 August 2020 
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Table 7. (SARS-CoV-2) COVID-19 fatality rate by state in Mexico 
as of August 1, 2020 
 Estado Total deceased Covid positives 19 Case fatality rate 
1 Aguascalientes 257 4,120 6.24% 
2 Baja California 2,674 13,594 19.67% 
3 Baja California Sur 182 4,498 4.05% 
4 Campeche 500 4,588 10.90% 
5 Chiapas 645 13,116 4.92% 
6 Chihuahua 194 1,875 10.35% 
7 Ciudad de México 7,244 74,314 9.75% 
8 Coahuila de Zaragoza 967 5,775 16.74% 
9 Colima 904 5,317 17.00% 
10 Durango 288 4,167 6.91% 
11 Guanajuato 1,009 21,378 4.72% 
12 Guerrero 1,415 11,032 12.83% 
13 Hidalgo 1,033 6,901 14.97% 
14 Jalisco 1,549 13,313 11.64% 
15 México 8,225 53,513 15.37% 
16 Michoacán de Ocampo 780 9,910 7.87% 
17 Morelos 836 4,101 20.39% 
18 Nayarit 391 3,518 11.11% 
19 Nuevo León 1,118 18,032 6.20% 
20 Oaxaca 968 10,673 9.07% 
21 Puebla 2,446 20,355 12.02% 
22 Querétaro 449 3,726 12.05% 
23 Quintana Roo 1,015 7,840 12.95% 
24 San Luis Potosí 522 9,921 5.26% 
25 Sinaloa 2,230 12,774 17.46% 
26 Sonora 1,949 17,890 10.89% 
27 Tabasco 1,988 21,747 9.14% 
28 Tamaulipas 1,008 17,130 5.88% 
29 Tlaxcala 713 4,627 15.41% 
30 Veracruz de Ignacio de la Llave 2,849 21,582 13.20% 
31 Yucatán 875 10,098 8.67% 
32 Zacatecas 249 2,768 9.00% 
 Total 47,472 434,193 10.93% 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
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Figure 1 Comorbidities identified in hospitalized patients with a positive 
result for (SARS-CoV-2) COVID-19, nationwide as 
of August 1, 2020 
 
Sex Age 
Sex =1 Women, Sex = 2 Men 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
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Table 8. Total number of cases in Veracruz State as of August 1, 2020, 
According to Sex and Result at (SARS-CoV-2) COVID-19 
 
 Sex  
Result Women  Men Total 
Positive (SARS-CoV-2) COVID-19 9,250  12,332 21,582 
No positive (SARS-CoV-2) COVID-19 5,663  4,865 10,518 
Pending result 1,285  1,519 2,804 
Total 16,198  18,706 34,904 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
 
Table 9. Total number of cases in the Nahuatl from the Pajapan  Zone 
in Mexico as of August 1, 2020, According to Sex and Result at (SARS- 
CoV-2) COVID-1 
 
 Sex  
Result Women  Men Total 
Positive (SARS-CoV-2) COVID-19 1,050  1,455 2,505 
No positive (SARS-CoV-2) COVID-19 692  582 1,274 
Pending result 91  97 188 
Total 1,748  2,134 3,967 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
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Table 10. Total number of cases with result positive at (SARS-CoV-2) 
COVID-19 in the Nahuatl from the Pajapan  Zone in Mexico as of 
August 1, 2020, according to sex, indigenous language speaker status 
and 
 
 
Result Women Men Total 
Indigenous language speaker 3 11 14 
Non-indigenous language speaker 1,035 1,422 2,457 
Not specified 12 22 34 
Total 1,050 1,455 2,505 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
 
 
Table 11. Total number of cases according to the result for (SARS-CoV-2) 
COVID-19 in the Nahuatl from the Pajapan  Zone in Mexico as of August 1, 
2020, according to sex and condition of speaker of an indigenous language 
 
 
 
Result  Positive (SARS- 
CoV-2) COVID 19 
Non Positive 
(SARS-CoV- 
2) COVID-19 
Pending 
result 
Indigenous language speaker 14 4 1 
Non-indigenous language speaker 2,457 1,250 187 
Not specified 34 20 0 
Total 2,505 1,274 188 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
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Table 12. Total number of cases with result positive at (SARS-CoV-2) COVID-19 
in the Nahuatl from the Pajapan  Zone in Mexico as of August 1, 2020, according 
to primary hospital care condition and indigenous language speaker status 
 
 
Result Non Hospitalized Hospitalized Total 
Indigenous language speaker 2 12 14 
Non-indigenous language speaker 1,254 1,203 2,457 
Not specified 12 22 34 
Total 1,268 1,237 2,505 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
 
 
Table 13. Total number of cases with result positive at (SARS-CoV-2) 
COVID-19 in the Nahuatl from the Pajapan  Zone in Mexico as of 
August 1, 2020, according to primary indigenous language speaker 
status and municipality 
 
 
Municipality  Speak 
indigenous 
language 
Non 
Speak 
indigenous 
Not specified Total 
  language  
 
Coatzacoalcos 4 1,470 20 1,494 
Cosoleacaque 2 284 3 289 
Mecayapan 0 3 0 0 
Minatitlan 5 677 10 692 
Oteapan 0 13 1 14 
Pajapan 1 1 0 2 
Soteapan 2 3 0 5 
Zaragoza 0 4 0 4 
Tatahuicapan de 
Juarez 
 
         0 
 
2 
 
0 
 
2 
Total 14 2,457 34 2,505 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
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Table 14. Total number of cases with result positive at (SARS-CoV-2) COVID-19 
in the Nahuatl from the Pajapan Zone in Mexico as of August 1, 2020, 
according to status according to primary hospital care condition 
in Intensive care unit 
 
 
Municipality Intensive 
care unit 
Non Intensive 
care unit 
Not 
specified 
Total 
 
 
 
Coatzacoalcos 0 4 0 4 
Cosoleacaque 0 1 1 2 
Minatitlan 0 4 1 5 
Pajapan 0                 1 0 1 
Soteapan 0 2 0 2 
Total 0 12 2 14 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
Figure 2 Comorbidities identified in hospitalized patients with a 
positive result for (SARS-CoV-2) COVID-19, in the Nahuatl from 
the Pajapan  Zone in Mexico of August 1, 2020 
 
 
Sex Age 
Sex =1 Women, Sex = 2 Men 
Source: Own elaboration with Government of Information from 
the Mexico. Health Secretary. Epidemiological Surveillance 
System for Viral Respiratory Diseases as of August 1, 2020 
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Map 1  Nahuatl from the Pajapan  Zone 
 
Source: Own elaboration. 
With Catálogo de metadatos geográficos. Comisión Nacional para el Conocimiento y Uso de la 
Biodiversidad. División política municipal, 1:250000. 2010. 
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